Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03555578
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
Sponsor: Takeda
View on ClinicalTrials.gov
Summary
The purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy (SBMA) in the routine clinical setting.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1890
Start Date
2017-11-02
Completion Date
2026-04-30
Last Updated
2025-10-07
Healthy Volunteers
No
Conditions
Interventions
DRUG
Leuprorelin Acetate
Leuprorelin Acetate Injection Kit
Locations (1)
Takeda Selected Site
Tokyo, Japan